During the past decade, Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" #1 sponsor was "Pfizer" with 7 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Akros Pharma Inc." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Bioskin GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" are "Psoriasis" (6 trials), "Dermatitis, Atopic" (4 trials), "Atopic Dermatitis" (3 trials), "Alopecia Areata" (2 trials) and "Eczema" (2 trials). Many other conditions were trialed in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" in a lesser frequency.

Most popular intervention types in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" are "Drug" (18 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BMS-986165" (2 trials), "Lebrikizumab" (2 trials), "PF-04965842 100 mg" (2 trials) and "PF-04965842 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dermoklinika Centrum Medyczne s.c., M. Kierstan, J. Narbutt, A. Lesiak, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".